Filing Details
Lunai Bioworks Inc. (NASDAQ:LNAI) filed a Form 8-K with the Securities and Exchange Commission on October 09, 2026, disclosing a material event.
8k filedNASDAQ:LNAI
Lunai Bioworks Inc. (LNAI) Reports Material Event to SEC
Lunai Bioworks Inc. (NASDAQ:LNAI) filed a Form 8-K with the Securities and Exchange Commission on October 09, 2026, disclosing a material event.
At publication ·
What changed
Lunai Bioworks Inc. (NASDAQ:LNAI) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Lunai Bioworks Inc. (NASDAQ: LNAI) filed a Form 8-K on October 09, 2026, disclosing a material event to the SEC.
- The company's stock trades at $1.23 with a market capitalization of $20.6 million.
- The 8-K filing addresses a material event that shareholders should know about, which could involve leadership changes, agreements, acquisitions, or asset sales.
- The specific nature of the disclosed event determines its significance for investors and the stock price impact.
Market Context
Lunai Bioworks Inc.'s stock currently trades at $1.23 with a market capitalization of $20.6M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Lunai Bioworks Inc.'s stock.
All SEC filings for Lunai Bioworks Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View LNAI Stock Page
Frequently Asked Questions
Where can I read LNAI's SEC filings?
Browse all filings on our LNAI SEC filings page.
What types of SEC filings does Lunai Bioworks Inc. file?
Public companies like Lunai Bioworks Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.